SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-023352
Filing Date
2021-05-04
Accepted
2021-05-04 16:16:07
Documents
13
Period of Report
2021-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K drrx-8k_20210504.htm   iXBRL 8-K 33703
2 EX-99.1 drrx-ex991_6.htm EX-99.1 275419
  Complete submission text file 0001564590-21-023352.txt   452701

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA drrx-20210504.xsd EX-101.SCH 5768
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE drrx-20210504_lab.xml EX-101.LAB 18717
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drrx-20210504_pre.xml EX-101.PRE 11167
6 EXTRACTED XBRL INSTANCE DOCUMENT drrx-8k_20210504_htm.xml XML 3437
Mailing Address 10260 BUBB ROAD CUPERTINO CA 95014
Business Address 10260 BUBB RD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

IRS No.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31615 | Film No.: 21888664
SIC: 2834 Pharmaceutical Preparations